Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Drug Monitoring of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (DOSE-HEP)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2010 by South West Sydney Local Health District.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
South West Sydney Local Health District
ClinicalTrials.gov Identifier:
NCT01078311
First received: March 1, 2010
Last updated: NA
Last verified: February 2010
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2014
  Estimated Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)